Published in Onco Targets Ther on January 10, 2017
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol (2010) 16.24
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
PCNA, the maestro of the replication fork. Cell (2007) 10.43
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
Language bias in randomised controlled trials published in English and German. Lancet (1997) 7.29
Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 4.36
A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol (1980) 3.50
Identity of the proliferating cell nuclear antigen and cyclin. Nature (1984) 3.44
PCNA on the crossroad of cancer. Biochem Soc Trans (2009) 2.03
Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp Cell Res (1981) 1.99
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol (2003) 1.46
Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer (1995) 1.26
PCNA: a silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci (2014) 1.23
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer (2012) 1.09
Overexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survival. Oncology (1998) 1.05
Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer. Med Oncol (2014) 1.03
Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth. Mol Cancer Ther (2011) 1.02
Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol (2011) 1.02
Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Mol Pharmacol (2012) 1.02
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology (2006) 1.01
Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides. PLoS One (2013) 1.00
Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol (2011) 0.99
Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol (2015) 0.96
Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer. Folia Histochem Cytobiol (2009) 0.93
The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene (2013) 0.93
Prognostic significance of p53 in gastric cancer: a meta- analysis. Asian Pac J Cancer Prev (2015) 0.91
Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett (2001) 0.88
CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis. Oncotarget (2015) 0.86
Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study. Oral Oncol (2001) 0.86
Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma. Pathol Oncol Res (2000) 0.85
Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value. Cytopathology (2004) 0.85
MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Histol Histopathol (2013) 0.85
New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee. Gastric Cancer (2014) 0.85
Increased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer (2002) 0.84
Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma. Am J Otolaryngol (2006) 0.82
Expression and significance of IGF-2, PCNA, MMP-7, and α-actin in gastric carcinoma with Lauren classification. Turk J Gastroenterol (2013) 0.82
Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma. Br J Cancer (1994) 0.82
Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis. Oncotarget (2016) 0.82
Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Oncol Rep (2011) 0.81
Proliferating Cell Nuclear Antigen Has an Association with Prognosis and Risks Factors of Cancer Patients: a Systematic Review. Mol Neurobiol (2015) 0.80
Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients. Cytometry (2000) 0.80
Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value. J Clin Pathol (1994) 0.80
Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer. J Surg Oncol (2011) 0.80
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PLoS One (2015) 0.79
Biological prognostic parameters in gastric carcinomas. Chirurgia (Bucur) (2014) 0.76
Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance. World J Gastroenterol (2004) 0.76